Searched for
PHARMA INGREDIENTS SECTOR
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- 20 months of bearish markets: One additional letter that tells you which 'cheap' stocks are actually cheapMost investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- June quarter earnings to determine market direction, says Sunil Subramaniam, warns on risks in near termMarket expert Sunil Subramaniam advised caution amid geopolitical uncertainty and rising input costs, while favouring consumer durables, ca...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Specialty chemicals: Is China still the same threat, or is this a contrarian moment? 7 stocks to be brought back on the watchlistWhen it comes to the Indian speciality chemicals sector, China and its dumping matters. But there have been subtle but significant changes ...
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Govt ramps up feedstock supplies to pharma sector amid West Asia disruptionsIndia's government is boosting petrochemical feedstock for drug makers. This ensures essential medicines remain available as global supply ...
- Israel-Iran war: India flags crunch in key pharma solvents used for life-saving drugs; govt moves to stabilise supplyIndia faces challenges with essential drug ingredient supplies. Geopolitical issues are impacting key solvents and feedstocks. However, dru...
- 'Allocate key chemicals to avert drug shortages', says Pharmexcil amid West Asia warIndian drug makers face a critical shortage of essential raw materials. Pharmexcil has asked the government to divert supplies of propylene...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...
- ETIG Analysis: Five reasons why the pharma sector has been the biggest beneficiary of the pandemicThe events of the recent months prompted the government to roll out an incentive scheme to promote the local production of key active ingre...
- Indian pharma sector will struggle without Govt support: IDMAIndian companies would struggle to grab opportunities that would arise when almost $ 30-40 billion drugs become off-patented in the next 3-...
Load More
